This enhanced GM-CSF secretion may be partially responsible for the demonstrated efficacy of the VC2 virus for melanoma in mice [27,28], as well as for breast cancer in mice (Nabi and Kousoulas, in preparation). Here, CSF2 is linked to breast carcinoma.